EAM
TXG icon

Erste Asset Management’s 10x Genomics TXG Stock Holding History

Erste Asset Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.86M Buy
+50,000
New +$1.31M 0.01% 389

Other funds holding TXG

SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CG
Caprock Group Boise, Idaho $5.22B AUM 42.47% 1-Year Est. Return
FC
Financial Consulate Hunt Valley, Maryland $899M AUM 20.23% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return
MCP
Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return
BEI
Benjamin Edwards Inc Clayton, Missouri $11B AUM 18.22% 1-Year Est. Return
AWA
Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Erste Asset Management's TXG Position: Q2 2026 in Review

Erste Asset Management opened a new position in 10x Genomics (TXG) in Q2 2026: 50,000 shares worth $1.86M. The stake represents 0.01% of the portfolio and ranks #389 among its holdings.

76 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Erste Asset Management held 50,000 shares of 10x Genomics worth $1.86M as of Q2 2026.
  • 10x Genomics was a new Erste Asset Management position in Q2 2026.
  • 10x Genomics made up 0.01% of Erste Asset Management's portfolio in Q2 2026, its #389 holding.
  • 76 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Erste Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.